ALK-Rearranged Non-Small Cell Lung Cancer in 2020: Real-World Triumphs in an Era of Multigeneration ALK-Inhibitor Sequencing Informed by Drug Resistance Profiling.
Itchins M, Lau B, Hudson AL, Westman H, Xia CY, Hayes SA, Howell VM, Rodriguez M, Cooper WA, Wei H, Buckland M, Li BT, Li M, Rathi V, Fox SB, Gill AJ, Clarke SJ, Boyer MJ, Pavlakis N.
Itchins M, et al. Among authors: howell vm.
Oncologist. 2020 Aug;25(8):641-649. doi: 10.1634/theoncologist.2020-0075. Epub 2020 Jul 2.
Oncologist. 2020.
PMID: 32558067
Free PMC article.